JPMorgan top economist says the Fed should cut rates by a half point this month

JPMorgan top economist says the Fed should cut rates by a half point this month


Key Points
  • JPMorgan’s top economist Michael Feroli believes the Federal Reserve should cut interest rates by a half point this month.
  • Traders are pricing in a 39% chance that the Fed’s target range for the federal funds rate will be lowered by a half percentage point, per the CME FedWatch Tool.
  • Feroli’s remarks come as August saw the weakest private payrolls growth in more than three-and-a-half years.



Source

Why BlackRock’s smallest deal of 2024 may end up being its most consequential
Finance

Why BlackRock’s smallest deal of 2024 may end up being its most consequential

BlackRock CEO Larry Fink has sent a clear message to investors: The world’s largest asset manager’s smallest acquisition last year could end up its most consequential. During an industry conference in March, the long-time executive said BlackRock’s $3.2 billion purchase of alternatives asset data provider Preqin — its smallest of the four deals announced in […]

Read More
Stocks making the biggest moves midday: Topgolf Callaway, Insmed, J.M. Smucker, SolarEdge & more
Finance

Stocks making the biggest moves midday: Topgolf Callaway, Insmed, J.M. Smucker, SolarEdge & more

Check out the companies making the biggest moves midday: Topgolf Callaway Brands — The stock popped 5%, adding to its nearly 15% surge in the previous session. Topgolf got a boost on Monday after a director disclosed the purchase of additional shares. Insmed – Shares surged more than 26% after the global biopharmaceutical company announced […]

Read More
Stocks making the biggest moves premarket: J.M. Smucker, Taiwan Semiconductor, Tesla and more
Finance

Stocks making the biggest moves premarket: J.M. Smucker, Taiwan Semiconductor, Tesla and more

Check out the companies making headlines before the bell. Insmed – Shares surged more than 26%. The global biopharmaceutical company announced positive results Tuesday from a Phase 2b study of treprostinil palmitil inhalation powder, a once-daily treatment for pulmonary arterial hypertension. J.M. Smucker – The food company’s stock pulled back about 8% after its fourth-quarter […]

Read More